Griffin states that "the reason we've picked 300 beds or larger hospitals is because those hospitals will have a high usage rate of the cuvettes..."
Yeah right, sure it is Griffin, you're targeting the big hospitals just to sell more of the cuvettes and not because very few smaller hospitals can afford to buy a picee of equipment for supplemental quality assurance! LOL
Ya'll best be lowering the price of those things so ALL hospitals can afford 'em, not just the cream-of-the-crop.
It appears as if the price skimming strategy of the newly launched Valimed was short lived. Not enough buyers at the 80K, even a 38% discount doesn't seem to be generating sales.
That's what can happen with a highly niche product, you're assured some sales, not a lot, just some.
Have they learned their lesson? NO! The meth gun will only detect meth at first, then a few other substances later.
Ahura's FirstDefender can detect over 2500 drugs, explosives and haz mats and can do probable analysis on over a million combinations of chemicals. It can see thru glass and plastic containers as well as open air.
How can the meth gun possibly compete? Answer: It detects trace amounts of meth in open air.
Another niche market. Good news, they're guaranteed some sales if it works reliably.
AI
